227 related articles for article (PubMed ID: 8307150)
21. Molecular pharmacology of the vesicular monoamine transporter.
Henry JP; Sagné C; Botton D; Isambert MF; Gasnier B
Adv Pharmacol; 1998; 42():236-9. PubMed ID: 9327887
[No Abstract] [Full Text] [Related]
22. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
Merickel A; Rosandich P; Peter D; Edwards RH
J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
[TBL] [Abstract][Full Text] [Related]
23. Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate.
Steiner-Mordoch S; Shirvan A; Schuldiner S
J Biol Chem; 1996 May; 271(22):13048-54. PubMed ID: 8662678
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.
Watson F; Deavall DG; Macro JA; Kiernan R; Dimaline R
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):193-9. PubMed ID: 9882615
[TBL] [Abstract][Full Text] [Related]
25. Vesicle monoamine transporters 1 and 2: differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla.
Mahata SK; Mahata M; Fischer-Colbrie R; Winkler H
Neurosci Lett; 1993 Jun; 156(1-2):70-2. PubMed ID: 8414192
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
[TBL] [Abstract][Full Text] [Related]
27. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
Peter D; Vu T; Edwards RH
J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690
[TBL] [Abstract][Full Text] [Related]
28. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
Hansson SR; Hoffman BJ; Mezey E
Brain Res Dev Brain Res; 1998 Sep; 110(1):135-58. PubMed ID: 9733951
[TBL] [Abstract][Full Text] [Related]
29. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
Schütz B; Schäfer MK; Eiden LE; Weihe E
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
[TBL] [Abstract][Full Text] [Related]
30. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2.
Finn JP; Edwards RH
J Biol Chem; 1998 Feb; 273(7):3943-7. PubMed ID: 9461580
[TBL] [Abstract][Full Text] [Related]
31. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
[TBL] [Abstract][Full Text] [Related]
32. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells.
Liu Y; Schweitzer ES; Nirenberg MJ; Pickel VM; Evans CJ; Edwards RH
J Cell Biol; 1994 Dec; 127(5):1419-33. PubMed ID: 7962100
[TBL] [Abstract][Full Text] [Related]
33. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.
Peter D; Jimenez J; Liu Y; Kim J; Edwards RH
J Biol Chem; 1994 Mar; 269(10):7231-7. PubMed ID: 8125935
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of a vesicular monoamine transporter by casein kinase II.
Krantz DE; Peter D; Liu Y; Edwards RH
J Biol Chem; 1997 Mar; 272(10):6752-9. PubMed ID: 9045708
[TBL] [Abstract][Full Text] [Related]
35. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
[TBL] [Abstract][Full Text] [Related]
36. Noncovalent and covalent labeling of vesicular monoamine transporter with tetrabenazine and ketanserin derivatives; purification of photolabeled protein.
Henry JP; Sagné C; Isambert MF; Gasnier B
Methods Enzymol; 1998; 296():73-83. PubMed ID: 9779441
[No Abstract] [Full Text] [Related]
37. Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans.
Varoqui H; Diebler MF; Meunier FM; Rand JB; Usdin TB; Bonner TI; Eiden LE; Erickson JD
FEBS Lett; 1994 Mar; 342(1):97-102. PubMed ID: 8143858
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal localization of the human vesicular amine transporter genes.
Peter D; Finn JP; Klisak I; Liu Y; Kojis T; Heinzmann C; Roghani A; Sparkes RS; Edwards RH
Genomics; 1993 Dec; 18(3):720-3. PubMed ID: 7905859
[TBL] [Abstract][Full Text] [Related]
39. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
Hansson SR; Mezey E; Hoffman BJ
Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
[TBL] [Abstract][Full Text] [Related]
40. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K
Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
